from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1267c/embR

LFCtreatmentdescriptionclass of inhibitor

0.410

Amikacinug/mL Amikacintranslation

0.797

Cap5-10ug/mL Capreomycintranslation

1.372

Rox10-50 ug/mL Roxithromycintranslation

-0.659

SM2-5 ug/mL Streptomycintranslation

0.023

Tet5-10 ug/mL Tetracyclinetranslation

1.326

Rif0.2-5ug/mL Rifampicintranscription

0.155

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.729

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.094

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.563

CPZ10-50 ug/mL Chlorpromazinerespiration

0.986

Clofazimine10-13 ug/mL Clofaziminerespiration

0.129

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.329

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.303

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.437

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.299

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.502

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.280

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.277

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.733

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.275

KCN5-20 ug/mL Potassium cyaniderespiration

1.209

NaN30.2-2 mM Sodium aziderespiration

-1.144

Nigericin50 uM Nigericinrespiration

-0.077

TRC10-150 ug/mL Triclosanrespiration

-0.175

TRZ10-25 ug/mL Thioridazinerespiration

-0.903

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.657

menadione6-10 ug/mL Menadionerespiration

0.024

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.013

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.364

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.382

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.073

NRP_1Non-replicating persistence stage 1dosRassociated

-0.712

Amp0.2mg/mL AmpicillincellWall

-0.486

Cephalexin20-100 ug/mL CephalexincellWall

-0.346

Cerulenin0.32-5 ug/mL CerulenincellWall

0.028

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.160

EMB10-20 ug/mL EthambutolcellWall

-0.550

Eta12-40 ug/mL EthionamidecellWall

-0.644

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.253

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.531

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.246

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.153

BZA0.12 mg/mL BenzamidearomaticAmides

0.257

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.937

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.204

H2O24 mM hydrogen peroxideDNAdamaging

-0.153

Levo10 ug/mL LevofloxacinDNAdamaging

-0.345

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.926

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.210

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.524

UVUV-irradiationDNAdamaging

-1.509

ARP41-4 ug/mL Antitubercular compound ARP4?

0.049

Antimycin12.5-50 ug/mL Antimycin A?

-0.232

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.255

PA_110-50 ug/mL Antitubercular compound PA-1?

0.444

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.351

PA8240.2-2 ug/mL PA-824?

-0.134

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.091

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.528

Verapamil50 uM Verapamil?

-0.436

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.083

methoxatin10-20 ug/mL Methoxatin?